Integrated Diagnostics Holdings plc
LSE: IDHC.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Hend El Sherbini
- Employees
- 6,309
- Headquarters
- Saint Helier, Jersey
- IPO year
- 2015
- Market cap
- $348.8M
- Website
- https://www.idhcorp.com
Loading IDHC…
Loading profile data…Frequently asked questions about IDHC
What does Integrated Diagnostics Holdings plc (IDHC.L) do?
Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company opera...
Where does IDHC.L trade?
Integrated Diagnostics Holdings plc (IDHC.L) trades on the London Stock Exchange.
What sector is IDHC.L in?
Integrated Diagnostics Holdings plc (IDHC.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Integrated Diagnostics Holdings plc?
Hend El Sherbini is the chief executive officer of Integrated Diagnostics Holdings plc (IDHC.L).
Where is Integrated Diagnostics Holdings plc headquartered?
Integrated Diagnostics Holdings plc is headquartered in Jersey.
Does IDHC.L pay a dividend?
Yes — Integrated Diagnostics Holdings plc (IDHC.L) paid a trailing twelve-month dividend of USD 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did IDHC.L go public?
Integrated Diagnostics Holdings plc (IDHC.L) completed its initial public offering in 2015.